Cited by 27Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsArtificial Intelligence in Healthcare

Predicting Conversion from MCI to AD Combining Multi-Modality Data and Based on Molecular Subtype

Open access
Li, Hai-Tao, Yuan, Shao-Xun, Wu, Jian-Sheng, Gu, Yu, Sun, Xiao·2021·Brain Sciences

Abstract

Alzheimer’s disease (AD) is a neurodegenerative brain disease in the elderly. Identifying patients with mild cognitive impairment (MCI) who are more likely to progress to AD is a key step in AD prevention. Recent studies have shown that AD is a heterogeneous disease. In this study, we propose a subtyping-based prediction strategy to predict the conversion from MCI to AD in three years according to MCI patient subtypes. Structural magnetic resonance imaging (sMRI) data and multi-omics data, including genotype data and gene expression profiling derived from peripheral blood samples, from 125 MCI patients were used in the Alzheimer’s Disease Neuroimaging Initiative (ADNI)-1 dataset and from 98 MCI patients in the ADNI-GO/2 dataset. A variational Bayes approximation model based on the multiple kernel learning method was constructed to predict whether an MCI patient will progress to AD within three years. In internal fivefold cross-validation within ADNI-1, we achieved an overall AUC of 0.83 (79.20% accuracy, 81.25% sensitivity, 77.92% specificity) compared to the model without subtyping, which achieved an AUC of 0.78 (76.00% accuracy, 77.08% sensitivity, 75.32% specificity). In external validation using ADNI-1 as a training set and ADNI-GO/2 as an independent test set, we attained an AUC of 0.78 (74.49% accuracy, 74.19% sensitivity, 74.63% specificity). Identifying MCI patient subtypes with omics data would improve the accuracy of predicting the conversion from MCI to AD. In addition to evaluating statistics, obtaining the significant sMRI, single nucleotide polymorphism (SNP) and mRNA expression data from peripheral blood of MCI patients is noninvasive and cost-effective for predicting conversion from MCI to AD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/brainsci11060674

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. [2]Le H. La B. Pa S. Da E. Annual Incidence of Alzheimer Disease in the United States Projected to the Years 2000 through 2050 Available online: https://pubmed.ncbi.nlm.nih.gov/11723367/ (accessed on 21 February 2021)
  2. [24]Wang J. Wonka P. Ye J. Lasso Screening Rules via Dual Polytope Projection NIPS San Diego, CA, USA 2013

Cited by

Sorted by citations

Authors
Li, H.-T., Yuan, S.-X., Wu, J.-S., Gu, Y., & Sun, X.
Affiliations
  • State Key Laboratory of Bioelectronics, School of Biological Science and Medical Engineering, Southeast University, Nanjing 210096, China
  • School of Geography and Biological Information, Nanjing University of Posts and Telecommunications, Nanjing 210023, China
  • State Key Laboratory of Digital Medical Engineering (CN)
Corresponding author
Sun, Xiao
Venue
Brain Sciences
Publisher
MDPI AG
Published
2021-05-21
Volume
11
Issue
6
Pages
674
ISSN
2076-3425 (ISSN-L)
OpenAlex
W3164268453
Cited by
27
References
37
Citations by year
2026: 9 · 2025: 4 · 2024: 5 · 2023: 5 · 2022: 3 · 2021: 1
FWCI
2.51
Type
journal article
Language
en
Open access
Locations
  • Brain Sciences (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Natural Science Foundation of China (81830053, 61972084)
  • Jiangsu Provincial Key Research and Development Program (BE2016002-3)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Health Professions › Health Information Management › Artificial Intelligence in Healthcare
Keywords
Alzheimer's disease, mild cognitive impairment, multi-omics integration, structural MRI, peripheral blood gene expression, single nucleotide polymorphisms, multiple kernel learning, disease heterogeneity, ADNI

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review